Supernus Pharmaceuticals, Inc.SUPNNASDAQ
LOADING
|||
Revenue Growth Recovery in Progress
Trending higher, below historical average, slight contraction.
Left:
||||
Year-over-year revenue growth rate
Latest
8.94%
↓ 55% below average
Average (9y)
19.81%
Historical baseline
Range
High:48.87%
Low:-8.95%
CAGR
-7.7%
Structural decline
| Period | Value |
|---|---|
| 2024 | 8.94% |
| 2023 | -8.95% |
| 2022 | 15.09% |
| 2021 | 11.41% |
| 2020 | 32.50% |
| 2019 | -3.95% |
| 2018 | 35.29% |
| 2017 | 40.57% |
| 2016 | 48.87% |
| 2015 | 18.34% |